These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18711158)

  • 21. Hereditary hemochromatosis: implications for South Dakota physicians.
    Stampe C; Weiland K
    S D Med; 2013 Jan; 66(1):15, 17-8. PubMed ID: 23342715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current directions in hemochromatosis research: towards an understanding of the role of iron overload and the HFE gene mutations in the development of clinical disease.
    Neff LM
    Nutr Rev; 2003 Jan; 61(1):38-42. PubMed ID: 12638463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hereditary hemochromatosis: molecular diagnosis and effect of treatment].
    Szczeklik W; Dropiński J; Dziedzina S; Szułdrzyński K; Biesiada G; Mach T; Sanak M
    Pol Arch Med Wewn; 2004 May; 111(5):593-6. PubMed ID: 15508811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland].
    Himmelmann A; Bortoluzzi L; Jansen S; Fehr J
    Schweiz Med Wochenschr; 2000 Aug; 130(31-32):1112-9. PubMed ID: 11008304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in hemochromatosis: a 2015 update : a summary of proceedings of the 2014 conference held under the auspices of Hemochromatosis Australia.
    Ekanayake D; Roddick C; Powell LW
    Hepatol Int; 2015 Apr; 9(2):174-82. PubMed ID: 25788196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hereditary hemochromatosis: impact of molecular and iron-based testing on the diagnosis, treatment, and prevention of a common, chronic disease.
    Press RD
    Arch Pathol Lab Med; 1999 Nov; 123(11):1053-9. PubMed ID: 10539907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revisiting hereditary hemochromatosis: current concepts and progress.
    Yen AW; Fancher TL; Bowlus CL
    Am J Med; 2006 May; 119(5):391-9. PubMed ID: 16651049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transferrin saturation phenotype and HFE genotype screening for hemochromatosis and primary iron overload: predictions from a model based on national, racial, and ethnic group composition in central Alabama.
    Barton JC; Acton RT
    Genet Test; 2000; 4(2):199-206. PubMed ID: 10953960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary hemochromatosis in north-eastern Romania.
    Voicu PM; Cojocariu C; Petrescu-Dănilă E; Stanciu C; Covic M; Rusu M; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):982-7. PubMed ID: 21495455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The S65C mutation in Spain. Implications for iron overload screening.
    Remacha AF; Barceló MJ; Sardà MP; Blesa I; Altés A; Baiget M
    Haematologica; 2000 Dec; 85(12):1324-5. PubMed ID: 11114141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changing aspects of HFE-related hereditary haemochromatosis and endeavours to early diagnosis.
    Jacobs EM; Verbeek AL; Kreeftenberg HG; van Deursen CT; Marx JJ; Stalenhoef AF; Swinkels DW; de Vries RA
    Neth J Med; 2007 Dec; 65(11):419-24. PubMed ID: 18079564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
    Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
    Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of porphyria cutanea tarda with hereditary hemochromatosis.
    Mehrany K; Drage LA; Brandhagen DJ; Pittelkow MR
    J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A primer for predicting risk of disease in HFE-linked hemochromatosis.
    Adams PC; Walker AP; Acton RT
    Genet Test; 2001; 5(4):311-6. PubMed ID: 11960576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of HFE genetic testing on clinical presentation of hereditary hemochromatosis: new epidemiological data.
    Scotet V; Le Gac G; Mérour MC; Mercier AY; Chanu B; Ka C; Mura C; Nousbaum JB; Férec C
    BMC Med Genet; 2005 Jun; 6():24. PubMed ID: 15929798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for hereditary hemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis.
    El-Serag HB; Inadomi JM; Kowdley KV
    Ann Intern Med; 2000 Feb; 132(4):261-9. PubMed ID: 10681280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic hemochromatosis update.
    Brissot P; Le Lan C; Lorho R; Gaboriau F; Lescoat G; Loréal O
    Acta Gastroenterol Belg; 2005; 68(1):33-7. PubMed ID: 15832585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Arthropathy of hereditary hemochromatosis].
    Rihl M; Kellner H
    Z Rheumatol; 2004 Feb; 63(1):22-9. PubMed ID: 14991275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary hemochromatosis.
    Fix OK; Kowdley KV
    Minerva Med; 2008 Dec; 99(6):605-17. PubMed ID: 19034258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload.
    Badar S; Busti F; Ferrarini A; Xumerle L; Bozzini P; Capelli P; Pozzi-Mucelli R; Campostrini N; De Matteis G; Marin Vargas S; Giorgetti A; Delledonne M; Olivieri O; Girelli D
    Am J Hematol; 2016 Jun; 91(4):420-5. PubMed ID: 26799139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.